- VX-222
-
- $2.00 / 1KG
-
2020-01-09
- CAS:1026785-59-0
- Min. Order: 1g
- Purity: 98%min
- Supply Ability: ask
|
| Product Name: | VX-222 | | Synonyms: | VX-222;5-(3,3-Dimethyl-1-butyn-1-yl)-3-[(cis-4-hydroxycyclohexyl)[(trans-4-methylcyclohexyl)carbonyl]amino]-2-thiophenecarboxylic acid;VCH 222;VCH222;VCH-222;VX-222, VCH222;VX-222 (VCH-222, LoMibuvir);2-Thiophenecarboxylic acid, 5-(3,3-dimethyl-1-butyn-1-yl)-3-[(cis-4-hydroxycyclohexyl)[(trans-4-methylcyclohexyl)carbonyl]amino]- | | CAS: | 1026785-59-0 | | MF: | C25H35NO4S | | MW: | 445.61 | | EINECS: | | | Product Categories: | Inhibitors;Inhibitor | | Mol File: | 1026785-59-0.mol |  |
| | VX-222 Chemical Properties |
| Boiling point | 640.5±55.0 °C(Predicted) | | density | 1.21 | | storage temp. | Store at -20°C | | solubility | ≥44.6 mg/mL in DMSO; insoluble in H2O; ≥97.2 mg/mL in EtOH | | form | solid | | pka | 3.67±0.10(Predicted) |
| | VX-222 Usage And Synthesis |
| Description | Lomibuvir is a non-nucleoside inhibitor of the RNA-directed RNA polymerase of hepatitis C virus (HCV; Ki = 17 nM) that inhibits primer-dependent RNA synthesis selectively over de novo RNA synthesis. It inhibits HCV replication in Huh7.5 cells expressing the 1b/Con1 HCV subgenomic replicon (EC50 = 5 nM). | | Uses | VX-222, s a novel, potent and selective inhibitor of HCV polymerase . | | Definition | ChEBI: 5-(3,3-dimethylbut-1-ynyl)-3-[(4-hydroxycyclohexyl)-[(4-methylcyclohexyl)-oxomethyl]amino]-2-thiophenecarboxylic acid is a thiophenecarboxylic acid. | | target | HCV RNA-dependent RNA polymerase |
| | VX-222 Preparation Products And Raw materials |
|